您的位置: 首页 > 农业专利 > 详情页

Novel a-Naphthylurea derivative and medical application of same
专利权人:
Ltd.;Radiant Pharma & Tech. Co.
发明人:
Hu, Yingjian,Luo, Zhibin,Zhang, Yanhong,Han, Li,Wang, Yun,Lu, Hongfei
申请号:
AU2014328190
公开号:
AU2014328190A1
申请日:
2014.08.20
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present invention relates to a novel a-Naphthylurea derivative. This substance can remarkably depress phosphorylation of VEGFR2 and PDGFR-β receptor protein tyrosine kinases at the level of nanomolar concentration, and is a novel protein tyrosine kinase depressor, which can be used to cure a disease or symptom induced by the protein tyrosine kinase, such as a malignant tumor or an eye disease accompanied by pathological new vessels.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充